uniQure Announces Major Presence at the European Society of Gene and Cell Therapy (ESGCT) Annual Meeting - uniQure (NASDAQ:QURE)
LEXINGTON, Mass. and AMSTERDAM, Oct. 24, 2023 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced